drugset / Trial / NCT01438359

A Drug-Drug Interaction Study of Furosemide and PA21

NCT01438359

Phase 1 Completed 42 enrolled Vifor Pharma
RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to determine if Furosemide is affected by PA21.

Timeline

Start
2011-07
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Furosemide Other / unclassified 40 mg
Subject PA21 Unknown 15 g

Indications

No indication recorded.